In treating glaucoma, educating the patient about their disease is a crucial step. In addition to finding an appropriate treatment plan, it’s important for the patient to understand the nature of their disease. Two specialists discussed how they help patients understand glaucoma and how testing and treatments options play in.

Corneal cell therapy is being investigated as a new approach for patients in need of corneal transplantation and treatment for corneal diseases. EyeWorld spoke to several physicians who have experience in this area to hear about specific approaches being developed, current status and results, and the future of these options.

With its approval in 2017, many physicians have several years of lessons learned with the Light Adjustable Lens (LAL, RxSight). With the more recent commercial launch of the LAL+, which has a modified aspheric surface to extend depth of focus slightly, ophthalmologists have even more to talk about.